中文
| Catalogue |
|
|
| Recommend Products |
CENTOGENE AG
United States, Manufacturer, Hits: 1180, Updated:4/11/2019
United States |
Company Profile
-
CENTOGENE is a rare disease company focused on transforming clinical, genetic, and biochemical data into medical solutions for patients. We are focused on bringing rationality to treatment decisions and accelerating the development of new orphan drugs by using our knowledge of the global rare disease market, including our epidemiological and clinical heterogeneity, and our innovative biomarkers.
As one of the largest rare disease companies worldwide, CENTOGENE is dedicated to transforming the science of genetic information into solutions and creating hope for our patients with rare diseases and their families. www.centogene.com
Company News
- CENTOGENE Expands Express COVID-19 Antigen Testing to Frankfurt Airport 11/26/2020
- Fujirebio Europe and CENTOGENE Enter Partnership to Provide Rapid SARS-CoV-2 Antigen Testing 11/10/2020
- CENTOGENE Opens Walk-In COVID-19 Testing Facility at Berlin Brandenburg Airport 11/9/2020
- CENTOGENE Receives FDA Emergency Use Authorization for SARS-CoV-2 RT-PCR Assay 10/20/2020
- Collaboration Between CENTOGENE and U-Diagnostics Increases COVID-19 Testing Capacities in the Net... 10/15/2020
- CENTOGENE Opens Walk-In COVID-19 Testing Facility at Düsseldorf Airport 9/24/2020
- CENTOGENE Expands COVID-19 Testing Capacity at Frankfurt Airport 9/11/2020
- CENTOGENE Publishes Huge Dataset that Supports Genome Sequencing as a First-Line Diagnostic Test 9/4/2020
- CENTOGENE Opens Walk-In COVID-19 Testing Facility at Hamburg Airport 8/19/2020
- CENTOGENE Supports Tajikistan in Fight Against the COVID-19 Pandemic 8/5/2020